Global Pharmatech Inc
Global Pharmatech, Inc., through its subsidiaries, discovers, develops, manufactures, and markets proprietary therapeutical products based on Traditional Chinese Medicine (TCM). The company was founded in 2001 and is based in Mong Kok, Hong Kong.
Global Pharmatech Inc (GBLP) - Net Assets
Latest net assets as of June 2025: $-61.69K USD
Based on the latest financial reports, Global Pharmatech Inc (GBLP) has net assets worth $-61.69K USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($854.68K) and total liabilities ($916.37K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-61.69K |
| % of Total Assets | -7.22% |
| Annual Growth Rate | N/A |
| 5-Year Change | -101.31% |
| 10-Year Change | N/A |
| Growth Volatility | 50.85 |
Global Pharmatech Inc - Net Assets Trend (2001–2024)
This chart illustrates how Global Pharmatech Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Global Pharmatech Inc (2001–2024)
The table below shows the annual net assets of Global Pharmatech Inc from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-120.33K | +40.03% |
| 2023-12-31 | $-200.64K | -2.13% |
| 2022-12-31 | $-196.45K | -298.77% |
| 2021-12-31 | $-49.26K | -100.54% |
| 2007-12-31 | $9.16 Million | -24.40% |
| 2006-12-31 | $12.11 Million | +47.02% |
| 2005-12-31 | $8.24 Million | +23.61% |
| 2005-03-31 | $6.67 Million | +2.00% |
| 2004-12-31 | $6.53 Million | +4669.53% |
| 2001-12-31 | $-143.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Global Pharmatech Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4048.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $152.88K | % |
| Other Comprehensive Income | $21.04K | % |
| Other Components | $11.95 Million | % |
| Total Equity | $-120.33K | 100.00% |
Global Pharmatech Inc Competitors by Market Cap
The table below lists competitors of Global Pharmatech Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CMG Cleantech S.A.
PA:MLCMG
|
$2.19K |
|
VINACONEX 21
VN:V21
|
$2.20K |
|
Glori Energy Technology Inc
PINK:GLRI
|
$2.21K |
|
Remala Abadi Tbk.
JK:DATA
|
$2.21K |
|
Jangada Mines Plc
LSE:JAN
|
$2.19K |
|
Indiabulls Enterprises Limited
NSE:IEL
|
$2.19K |
|
AlphaGen Intelligence Corp.
F:G4G
|
$2.19K |
|
OCH.JSC
VN:OCH
|
$2.18K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Global Pharmatech Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -200,641 to -120,333, a change of 80,308.
- Net loss of 67,728 reduced equity.
- Share repurchases of 4,850 reduced equity.
- Other comprehensive income increased equity by 117,277.
- Other factors increased equity by 35,609.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-67.73K | -56.28% |
| Share Repurchases | $4.85K | -4.03% |
| Other Comprehensive Income | $117.28K | +97.46% |
| Other Changes | $35.61K | +29.59% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Global Pharmatech Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | $0.03 | $0.24 | x |
| 2005-12-31 | $0.41 | $0.24 | x |
| 2006-12-31 | $0.51 | $0.24 | x |
| 2007-12-31 | $0.35 | $0.24 | x |
| 2021-12-31 | $0.00 | $0.24 | x |
| 2022-12-31 | $0.00 | $0.24 | x |
| 2023-12-31 | $0.00 | $0.24 | x |
| 2024-12-31 | $0.00 | $0.24 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Global Pharmatech Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -21.78%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-4.17%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 5.34% | 19.93% | 0.16x | 1.65x | $-270.43K |
| 2005 | 2.76% | 6.51% | 0.25x | 1.68x | $-525.55K |
| 2006 | -11.11% | -51.96% | 0.15x | 1.45x | $-2.35 Million |
| 2007 | -30.37% | -86.74% | 0.21x | 1.66x | $-3.25 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-108.39K |
| 2022 | 0.00% | -35.85% | 0.14x | 0.00x | $-1.36K |
| 2023 | 0.00% | -208.66% | 0.16x | 0.00x | $-118.43K |
| 2024 | 0.00% | -21.78% | 0.41x | 0.00x | $-55.69K |
Industry Comparison
This section compares Global Pharmatech Inc's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $5,681,533,529
- Average return on equity (ROE) among peers: 0.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Global Pharmatech Inc (GBLP) | $-61.69K | 5.34% | N/A | $2.19K |
| Above Food Ingredients Inc. Common Stock (ABVE) | $30.90K | -3.31% | 7.66x | $18.76 Million |
| The a2 Milk Company Limited (ACOPF) | $7.27 Million | -30.19% | 0.14x | $3.91 Billion |
| Ayujoy Herbals Ltd (AJOY) | $22.20 Million | 29.29% | 0.00x | $95.71 |
| Alfa S.A.B. de C.V (ALFFF) | $53.35 Billion | 7.36% | 3.80x | $2.16 Billion |
| Amincor Inc (AMNCB) | $34.44 Million | -63.76% | 0.81x | $2.24K |
| Armanino Foods New (AMNF) | $21.40 Million | 30.30% | 0.33x | $72.33K |
| Amira Nature Foods Ltd (ANFIF) | $303.22 Million | 8.27% | 0.89x | $128.79 |
| AAK AB (publ.) (ARHUF) | $2.44 Billion | 12.85% | 2.63x | $5.07 Billion |
| Artisan Consumer Goods Inc (ARRT) | $-326.75K | 0.00% | 0.00x | $279.39K |
| ARYZTA AG (ARZTF) | $632.10 Million | 9.58% | 2.04x | $53.13 Million |